Trial Outcomes & Findings for Study of the Effectiveness of Green Diode Laser Light on Body Shaping (NCT NCT01292538)

NCT ID: NCT01292538

Last Updated: 2020-02-10

Results Overview

Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

67 participants

Primary outcome timeframe

2 weeks

Results posted on

2020-02-10

Participant Flow

Participant milestones

Participant milestones
Measure
Erchonia GLS 532nm
532nm green laser light therapy. Erchonia GLS: 532 nm green diode low level laser light device
Placebo Laser
Sham light output with no therapeutic benefit Placebo laser: Sham light output with no therapeutic benefit
Overall Study
STARTED
35
32
Overall Study
COMPLETED
35
32
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Study of the Effectiveness of Green Diode Laser Light on Body Shaping

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Erchonia GLS 532nm
n=35 Participants
532nm green laser light therapy. Erchonia GLS: 532 nm green diode low level laser light device
Placebo Laser
n=32 Participants
Sham light output with no therapeutic benefit Placebo laser: Sham light output with no therapeutic benefit
Total
n=67 Participants
Total of all reporting groups
Age, Continuous
36.60 years
STANDARD_DEVIATION 10.05 • n=5 Participants
39.03 years
STANDARD_DEVIATION 10.16 • n=7 Participants
38.04 years
STANDARD_DEVIATION 10.08 • n=5 Participants
Sex: Female, Male
Female
28 Participants
n=5 Participants
25 Participants
n=7 Participants
53 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
7 Participants
n=7 Participants
14 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
29 Participants
n=5 Participants
32 Participants
n=7 Participants
61 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
6 Participants
n=5 Participants
0 Participants
n=7 Participants
6 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 2 weeks

Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.

Outcome measures

Outcome measures
Measure
Erchonia GLS 532nm
n=35 Participants
532nm green laser light therapy. Erchonia GLS: 532 nm green diode low level laser light device
Placebo Laser
n=32 Participants
Sham light output with no therapeutic benefit Placebo laser: Sham light output with no therapeutic benefit
Combined Circumference in Inches of the Waist, Hips and Bilateral Thighs
-3.895 inches
Standard Deviation 3.03
-1.136 inches
Standard Deviation 2.27

Adverse Events

Erchonia GLS 532nm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Placebo Laser

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Elvira Walls

Regulatory Insight, Inc.

Phone: 615-712-9743

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place